Drug boosting survival hopes for breast cancer sufferers5th June 2007
Cancer drug Hercepin, could reduce the number of mastectomies if used alongside chemotherapy before women undergo surgery, a study has shown. Women who suffer from a certain type of breast cancer, HER-2-positive, who are treated in this way were more likely to see tumours shrink substantially, meaning surgery that would conserve the bresat can be carrid out, according to new stattistics.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Drug boosting survival hopes for breast cancer sufferers
Author: Anne Waller
Article Id: 3044
Date Added: 5th Jun 2007